Andrew D Galbreath

Learn More
The treatment of Parkinson disease (PD) involves pharmacological treatment, often with levodopa or dopamine agonists, to restore the dopaminergic deficit associated with parkinsonian symptoms. Either agent provides symptom relief that becomes less effective in the course of PD, and switching or combining these agents or adding other therapies becomes(More)
There is currently no satisfactory treatment for dyskinesia in patients with Parkinson disease because most antidyskinetic strategies have the effect of aggravating Parkinsonian symptoms, and most pharmacological strategies for reducing "off" periods have increased dyskinesia as a treatment complication. Therefore, physicians and patients often have to(More)
We describe a patient in whom dysnomia, ataxia, choreoathetosis, sensory impairment, and severe gait imbalance resulted from an isolated left lentiform nucleus-posterior limb of internal capsule lacunar stroke. Each of these deficits has been described as a consequence of unilateral basal ganglia or internal capsule infarction in prior reports, but the(More)
  • 1